BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Pharma Journalist - ECPv6.16.1//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Pharma Journalist
X-ORIGINAL-URL:http://www.pharmajournalist.com
X-WR-CALDESC:Events for Pharma Journalist
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Asia/Kolkata
BEGIN:STANDARD
TZOFFSETFROM:+0530
TZOFFSETTO:+0530
TZNAME:IST
DTSTART:20240101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20250401
DTEND;VALUE=DATE:20250404
DTSTAMP:20260515T094341
CREATED:20241127T123831Z
LAST-MODIFIED:20241127T123902Z
UID:40151-1743465600-1743724799@www.pharmajournalist.com
SUMMARY:Nasal Formulation & Delivery Summit
DESCRIPTION:With nasal delivery systems offering faster absorption and non-invasive administration\, they are becoming a cornerstone of modern therapeutics. Whether for nose-to-brain delivery or emergency use\, nasal delivery is opening a new era of more efficient drug and vaccine administration with life-saving potential. However\, challenges in biologics formulation\, along with renewed interest from major pharmaceutical companies and investors\, raise questions about how other companies are addressing development obstacles and the most effective strategies to secure funding. \nDedicated to navigating investment pathways for nasal companies\, boosting drug bioavailability in target regions\, optimizing translational modelling\, and determining the efficacy of delivery devices\, the 3rd Nasal Formulation & Delivery Summit will unite biotechs and innovative start-ups to share case studies and best practices in optimizing nasal drug delivery across different therapeutic areas. \nDownload the event guide for full details: https://ter.li/qd1z5z \nEarly bird savings and group discounts up to 20% are available\, check out the options here: https://ter.li/u7ehtp
URL:http://www.pharmajournalist.com/event/nasal-formulation-delivery-summit/
LOCATION:Revere Hotel Boston Common\, 200 Stuart Street\, Boston\, 02116\, United States
ORGANIZER;CN="Hanson Wade":MAILTO:info@hansonwade.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20250401
DTEND;VALUE=DATE:20250404
DTSTAMP:20260515T094341
CREATED:20241204T190232Z
LAST-MODIFIED:20241204T190232Z
UID:40220-1743465600-1743724799@www.pharmajournalist.com
SUMMARY:2nd Peptide-Based Therapeutics Summit
DESCRIPTION:The 2nd Peptide-Based Therapeutics Summit will return to Boston in April 2025\, bringing together over 80 experts in peptide computational science\, medicinal chemistry\, and formulation to discuss the latest advancements shaping the next generation of peptide-based therapies—from early-stage discovery to clinical application. \nDownload the three-day program here: https://ter.li/rrvg1v \nThis year’s summit will highlight groundbreaking innovations in peptide therapeutics\, including: \n\nPeptide 3D structure prediction\, hit generation\, and lead optimization\, featuring insights from Chugai Pharmaceutical\, PeptiDream\, and Insamo\nStrategies for optimizing oral bioavailability and cell permeability in peptide design\, with contributions from Orbis Medicines and Ohio State University\nPeptide formulation techniques for optimal target binding\, solubility\, stability\, and safety\, with expertise from Halozyme and Oramed Pharmaceuticals\n\nJoin us to shape your peptide drug discovery and development strategy for 2025 and discover the therapeutic potential of cutting-edge peptide-based medicines.
URL:http://www.pharmajournalist.com/event/2nd-peptide-based-therapeutics-summit/
LOCATION:Hilton Boston Back Bay\, 40 Dalton St\, Boston\, MA\, 02115\, United States
ORGANIZER;CN="Hanson Wade":MAILTO:info@hansonwade.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20250401
DTEND;VALUE=DATE:20250404
DTSTAMP:20260515T094341
CREATED:20250127T201431Z
LAST-MODIFIED:20250127T201431Z
UID:40370-1743465600-1743724799@www.pharmajournalist.com
SUMMARY:6th TCR-Based Therapies Summit
DESCRIPTION:Returning as the only event created selectively for and by the TCR community\, the 6th TCR-based Therapies Summit (April 1-3\, 2025 | Boston\, MA) is your unique opportunity to connect and collaborate with TCR developers and experts to battle the specific discovery\, preclinical and clinical challenges created by T cell receptor biology to advance cell- and bispecific approaches. \nView the 25+ experts speaking in 2025 including Adaptimmune\, Immunocore\, Immatics\, BioNTech\, T-Knife\, TScan\, and Affini-T Therapeutics. \nView the full lineup of presenting companies in the 2025 Event Guide. \nReturning as a much-loved forum by industry leaders in this close-knit community\, I’m sure you want to know what’s new for the 2025 meeting: \n\nPlethora of new data: Over 60% of talks will share new data\, including clinical insights and advances\, novel target case studies\, and innovations utilizing AI\, machine learning\, engineering methods\, and cell tracking\nBreadth of TCR Approaches: Uncover the realm of TCR targeting methods including TCR-Ts\, TCR-NKs\, bispecifics\, T-cell engagers\, TCR-like antibodies\, and mimics\, and distinguishing the optimal approach for different indications\n7 New Companies & 85% New Speakers: Unlock innovations from companies such as Moonlight Bio\, Synteny\, Alkemist Bio\, Pan Cancer T\, and Aethon Therapeutics making their TCR-Based Therapies Summit debut and hear new perspectives from a highly refreshed speaker faculty\nApplications Beyond Oncology: Discover how TCR therapies can be utilized to treat novel indications\, such as autoimmunity and infectious diseases\, and harness cross-learnings to propel your therapeutic development\n\nView the full program. \nFollowing Adaptimmune’s milestone approval\, the 2025 meeting is anticipated to be one of the best yet. With so much to celebrate\, momentum to capture\, novel insights\, and collaboration with like-minded experts at the only TCR-specific event. \nQuick links: Website | Event Guide | Register
URL:http://www.pharmajournalist.com/event/6th-tcr-based-therapies-summit/
LOCATION:The Revere Hotel Boston Common\, 200 Stuart St\, Boston\, MA\, 02116\, United States
ORGANIZER;CN="Hanson Wade":MAILTO:info@hansonwade.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20250408
DTEND;VALUE=DATE:20250411
DTSTAMP:20260515T094341
CREATED:20250214T121248Z
LAST-MODIFIED:20250214T121248Z
UID:40497-1744070400-1744329599@www.pharmajournalist.com
SUMMARY:15th World Clinical Biomarkers & Companion Diagnostics Summit Europe
DESCRIPTION:As recent advances in small molecules\, ADCs\, cell\, and gene therapies poise novel precision therapies from the bench to the clinic\, the 15th World Clinical Biomarkers & Companion Diagnostics Summit Europe returns as the industry-leading end-to-end forum for Europe’s precision medicine community. \nOver three days\, 170+ key stakeholders from across Europe working in Biomarkers\, Translational Medicine\, Precision Medicine\, and Companion Diagnostics will come together to: \n\nBolster biomarker discovery and validation\nImplement novel technologies and trials\nPioneer digital and AI-enabled innovations\nOptimise drug-diagnostic co-development\nStreamline CDx development and commercialisation\nNavigate IVDR-adherence\n\nWhen? 8th-10th April\, 2025 \nWhere? London\, UK \nSee the brochure: https://ter.li/exx85v \nWith free* tickets available for biopharma\, check our T&Cs\, or view our early bird savings and group discounts: https://ter.li/5uhfl8
URL:http://www.pharmajournalist.com/event/15th-world-clinical-biomarkers-companion-diagnostics-summit-europe/
LOCATION:London\, United Kingdom
ORGANIZER;CN="Hanson Wade":MAILTO:info@hansonwade.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20250409
DTEND;VALUE=DATE:20250411
DTSTAMP:20260515T094341
CREATED:20250228T122457Z
LAST-MODIFIED:20250228T122457Z
UID:40603-1744156800-1744329599@www.pharmajournalist.com
SUMMARY:Tumour Models Summit Nordics
DESCRIPTION:Welcome to the first ever Tumour Models Summit Nordics. This April\, the critically acclaimed Tumour Models series will be coming to the Nordics for the first time ever\, uniting more than seventy pharma\, biotech\, and research leaders across the Nordic biotech landscape. \nThe inherent heterogeneity of cancer – both inter-patient and intra-tumoral – remains a significant challenge in cancer modelling. With only 5% of cancer drugs successfully advancing to clinical trials\, there is a critical need for more accurate and predictive models to guide therapeutic development. \nTo serve this need\, the Tumour Models Summit Nordics will unite pharma\, biotech\, and research leaders from across the thriving Nordic biotech ecosystem to tackle this challenge head-on for the first time ever. Experts working across preclinical\, translational\, discovery\, toxicity\, and biology will gather in Stockholm this April to collaborate and overcome the industry’s biggest obstacles for 2025. As the region’s only industry-led event of its kind\, this summit provides a rare opportunity to connect with top experts from these developmental areas. \nGain insights into the cutting-edge innovation in in vivo and in vitro tumour modelling\, discover strategies to de-risk your studies\, and learn how to refine your drug development pipeline. \nKey highlights of the agenda include: \n\nLeveraging cutting-edge 3D in vitro models with Roche\nTarget/receptor axis modelling with Anocca\nHumanised mouse models with BioInvent\nAdvanced omics data with Curacell\nTreating solid tumours with Hemispherian\n\nPrevious attendees of the Tumour Models Summits in Boston\, San Francisco\, and London have celebrated the summit’s range\, relevance\, and focus with comments such as\, “This summit included the most cutting-edge achievements and potential collaborations in the scientific and industrial world” (Roche)\, and “The conference exceeded my expectations. The talks were very relevant to my day-to-day work as in vivo scientist in a cell therapy company. I enjoyed the networking; attendees were very approachable” (Arsenal Biosciences). \nFind out why they said this and secure your free pass to join us to engage with decision-makers\, explore groundbreaking solutions\, and accelerate the path from lab to patient in today’s rapidly evolving landscape. \nWe’ll see you there! \nGet your free pass now whilst still available: https://ter.li/qdc9zo
URL:http://www.pharmajournalist.com/event/tumour-models-summit-nordics/
LOCATION:Hilton Stockholm Slussen\, Guldgränd 8\, Stockholm\, 104 65\, Sweden
ORGANIZER;CN="Hanson Wade":MAILTO:info@hansonwade.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20250422
DTEND;VALUE=DATE:20250425
DTSTAMP:20260515T094341
CREATED:20241128T082522Z
LAST-MODIFIED:20241128T082522Z
UID:40196-1745280000-1745539199@www.pharmajournalist.com
SUMMARY:LEAP HR: Life Sciences West
DESCRIPTION:LEAP HR: Life Sciences West is your chance to explore how leading and emerging biopharma organizations are navigating industry volatility and preparing for the workforce of tomorrow. As the sector recovers from funding challenges and workforce reductions\, discover innovative ways to align your HR strategy with evolving business needs in 2025 and beyond. \nJoin 200+ HR leaders to uncover how the most agile organizations are reshaping total rewards strategies to gain a competitive edge in a fiercely competitive talent market. Learn how they’re redefining employee engagement to boost retention and creating flexible workforce planning strategies to adapt to rapid industry changes. \nThis is your opportunity to rethink HR practices and position your organization for long-term success in Life Sciences. \nTo know more visit: https://ter.li/fxwk88
URL:http://www.pharmajournalist.com/event/leap-hr-life-sciences-west/
LOCATION:Grand Hyatt San Francisco\, 345 Stockton St\, San Francisco\, CA\, 94108\, United States
ORGANIZER;CN="Hanson Wade":MAILTO:leaphr@hansonwade.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20250428
DTEND;VALUE=DATE:20250501
DTSTAMP:20260515T094341
CREATED:20250116T115710Z
LAST-MODIFIED:20250116T115805Z
UID:40311-1745798400-1746057599@www.pharmajournalist.com
SUMMARY:4th ADC Analytical Development Summit
DESCRIPTION:Unlock the Future of ADC Analytics at the 4th ADC Analytical Development Summit! \nWhen: April 2025\nWhere: Boston \nThe 4th ADC Analytical Development Summit is back\, bringing together top minds and innovators to tackle the unique analytical challenges of antibody-drug conjugates. With ADCs becoming more complex and regulatory requirements tightening\, this event will be your ultimate guide to mastering strategies that ensure high-quality products and seamless regulatory submissions. \nView the program here: https://ter.li/hi4hm1 \n\nWhy You Can’t Miss This Summit: \n3 Days of Cutting-Edge Scientific Content \nExplore sessions that cover critical topics\, including: \n\nOptimizing DAR quantification\nImproving aggregation analysis\nRefining impurity profiling for advanced ADC development\n\n25+ Expert Speakers \nLearn from top industry leaders and innovators\, featuring experts from: \n\nAstraZeneca\nAbbVie\nSutro Biopharma\nMerck\n…and many more!\n\n6+ Hours of Interactive Workshops \nParticipate in hands-on workshops to dive deeper into: \n\nStrategies for accelerated approvals\nAdvanced profiling techniques for product characterization\nPotency optimization for improved therapeutic outcomes\nCrafting data packages for smooth regulatory submissions\n\n5+ Hours of High-Impact Networking \nConnect with over 120 analytical scientists and quality control specialists to build valuable collaborations and share expertise. \nFind out more here: https://ter.li/hi4hm1
URL:http://www.pharmajournalist.com/event/4th-adc-analytical-development-summit/
LOCATION:Hilton Boston Back Bay\, 40 Dalton St\, Boston\, MA\, 02115\, United States
ORGANIZER;CN="Hanson Wade":MAILTO:info@hansonwade.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20250429
DTEND;VALUE=DATE:20250502
DTSTAMP:20260515T094341
CREATED:20250204T091737Z
LAST-MODIFIED:20250204T091823Z
UID:40418-1745884800-1746143999@www.pharmajournalist.com
SUMMARY:2nd Measuring Patient Engagement Summit
DESCRIPTION:As the healthcare industry evolves\, patient engagement has become a crucial factor in shaping clinical trials\, accelerating regulatory approvals\, and improving the overall patient experience. \nYet\, amidst a challenging funding environment\, empowered patients rightfully demanding greater involvement in treatment decisions\, and regulatory bodies requiring transparent reporting of patient engagement activities\, it has become more critical than ever to establish quantitative measures for assessing the impact of these initiatives. \nThe 2nd Annual Measuring Patient Engagement Summit 2025 is the premier event dedicated to addressing this challenge. Bringing together top experts from Patient Engagement\, Advocacy\, Affairs\, Experience\, Insights\, and Marketing\, this summit offers a platform for thought leaders to share data-driven strategies and actionable insights. Attendees will explore innovative case studies that showcase how patient engagement initiatives can be effectively measured\, ensuring they deliver real impact while meeting compliance and ROI expectations. \nKey topics will include: \n\nEstablishing standardized metrics for patient engagement success\nAligning patient engagement strategies with regulatory expectations\nDemonstrating ROI to internal and external stakeholders\nLeveraging patient insights to improve trial design and healthcare outcomes\n\nBy uniting industry leaders to develop a consistent framework for measuring patient engagement\, this event ensures that patient-centered innovation remains at the forefront of healthcare transformation. \nJoin us to drive measurable\, meaningful progress in patient engagement — because when we quantify what matters\, we create a healthcare system that works for everyone. \nTo know more visit: www.measuring-patient-engagement-summit.com
URL:http://www.pharmajournalist.com/event/2nd-measuring-patient-engagement-summit/
LOCATION:Hilton Boston Logan Airport\, One Hotel Dr\, Boston\, MA\, 02128\, United States
ORGANIZER;CN="Hanson Wade":MAILTO:info@hansonwade.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20250429
DTEND;VALUE=DATE:20250502
DTSTAMP:20260515T094341
CREATED:20250317T140929Z
LAST-MODIFIED:20250317T140929Z
UID:40719-1745884800-1746143999@www.pharmajournalist.com
SUMMARY:2nd GLP-1-Based Therapeutics Summit
DESCRIPTION:The 2nd GLP-1-Based Therapeutics Summit is an exclusive gateway to competitive intelligence into the continued potential of cutting-edge GLP-1s for obesity\, weight loss\, diabetes\, and beyond. Join us to hear the latest clinical data on combination therapies to enhance muscle preservation\, indication expansion into new areas\, and strategies to improve the efficacy\, tolerability\, and durability of GLP-1s. With these drugs continuing to dominate the headlines\, there is no better time to unite with 100+ C-level executives\, decision-makers\, and scientists at the forefront of the rapidly evolving world of GLP-1-Based therapeutics. \nLearn more: https://ter.li/b0yt9f
URL:http://www.pharmajournalist.com/event/2nd-glp-1-based-therapeutics-summit/
LOCATION:Wyndham Boston Beacon Hill\, 5 Blossom St\, Boston\, MA\, 02114\, United States
ORGANIZER;CN="Hanson Wade":MAILTO:info@hansonwade.com
END:VEVENT
END:VCALENDAR